News Feeds

HealthFolk's News section is a health news aggregator with a focus on Nigeria, and Africa as a whole.

[Correspondence] SGLT-2 inhibitors for people with type 2 diabetes

Tags: General

Evidence that sodium-glucose co-transporter-2 inhibitors (SGLT2i) can reduce cardiovascular risk—with trials
  • Minze MG
  • Will KJ
  • Terrell BT
  • Black RL
  • Irons BK
Benefits of SGLT2 inhibitors beyond glycemic control - a focus on metabolic, cardiovascular and renal outcomes.